{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:46:27Z","timestamp":1773769587144,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270206"],"award-info":[{"award-number":["81270206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470391"],"award-info":[{"award-number":["81470391"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Med-X Foundation","award":["YG2014MS49"],"award-info":[{"award-number":["YG2014MS49"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Certain early-phase clinical trials have suggested that bone marrow-derived stem cell transplantation might improve left ventricular function in patients with non-ischaemic dilated cardiomyopathy (NIDCM), whereas others trials have revealed no benefit from this approach. We sought to evaluate the therapeutic effects of bone marrow-derived stem cell therapy on NIDCM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched the PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases (through February 2016) for randomised controlled clinical trials that reported on bone marrow-derived stem cell transplantation for patients with NIDCM with a follow-up period \u226512\u00a0months. The co-primary endpoints were changes in mortality rate and left ventricular ejection fraction (LVEF); the secondary endpoints were changes in the 6-minute-walk test (6MWT) and left ventricular chamber size. Seven trials involving bone marrow-derived stem cell therapy that included 482 patients satisfied the inclusion and exclusion criteria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Subjects who received bone marrow-derived stem cell therapy exhibited a significant reduction in mortality rate (19.7% in the cell group vs. 27.1% in the control group; 95% confidence interval (CI) \u20130.16 to \u20130.00, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200952%, <jats:italic>p<\/jats:italic>\u2009=\u20090.04). Bone marrow-derived stem cell therapy tended to produce LVEF improvement within 6\u00a0months (1.83% increase; 95% CI \u20130.27 to 3.94, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200974%, <jats:italic>p<\/jats:italic>\u2009=\u20090.09) and significantly improved LVEF after mid-term (6\u201312 months) follow-up (3.53% increase; 95% CI 0.76 to 6.29, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200988%, <jats:italic>p<\/jats:italic>\u2009=\u20090.01). However, this therapy produced no significant benefit in the 6MWT (<jats:italic>p<\/jats:italic>\u2009=\u20090.18). Finally, the transplantation of increased numbers of stem cells resulted in no observable additional benefit with respect to LVEF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Bone marrow-derived stem cell therapy might have improved prognoses and appeared to provide moderate benefits in cardiac systolic function at mid-term follow-up. However, this therapy produced no observed improvement in exercise tolerance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-016-0441-x","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T13:09:49Z","timestamp":1481288989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A systematic review of randomised controlled trials examining the therapeutic effects of adult bone marrow-derived stem cells for non-ischaemic dilated cardiomyopathy"],"prefix":"10.1186","volume":"7","author":[{"given":"Yi","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menglu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiale","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,9]]},"reference":[{"issue":"53","key":"441_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"2009","author":"SA Hunt","year":"2009","unstructured":"Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. Focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;2009(53):e1\u201390.","journal-title":"J Am Coll Cardiol"},{"key":"441_CR2","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/0002-9149(92)90901-A","volume":"69","author":"TA Manolio","year":"1992","unstructured":"Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Michels VV, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol. 1992;69:1458\u201366.","journal-title":"Am J Cardiol"},{"key":"441_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jjcc.2008.06.001","volume":"52","author":"T Kubo","year":"2008","unstructured":"Kubo T, Matsumura Y, Kitaoka H, Okawa M, Hirota T, Hamada T, et al. Improvement in prognosis of dilated cardiomyopathy in the elderly over the past 20\u00a0years. J Cardiol. 2008;52:111\u20137.","journal-title":"J Cardiol"},{"key":"441_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.108.191259","volume":"119","author":"D Lloyd-Jones","year":"2009","unstructured":"Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics\u20142009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:480\u20136.","journal-title":"Circulation"},{"key":"441_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","volume":"112","author":"B Vrtovec","year":"2013","unstructured":"Vrtovec B, Poglajen G, Lezaic L, Sever M, Domanovic D, Cernelc P, et al. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res. 2013;112:165\u201373.","journal-title":"Circ Res"},{"key":"441_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cardfail.2010.11.007","volume":"17","author":"B Vrtovec","year":"2011","unstructured":"Vrtovec B, Poglajen G, Sever M, Lezaic L, Domanovic D, Cernelc P, et al. Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J Card Fail. 2011;17:272\u201381.","journal-title":"J Card Fail"},{"key":"441_CR7","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.jacc.2009.11.070","volume":"55","author":"S Seth","year":"2010","unstructured":"Seth S, Bhargava B, Narang R, Ray R, Mohanty S, Gulati G, et al. The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial: a long-term follow-up study. J Am Coll Cardiol. 2010;55:1643\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"441_CR8","first-page":"437","volume":"29","author":"RT Sant\u2019Anna","year":"2014","unstructured":"Sant\u2019Anna RT, Fracasso J, Valle FH, Castro I, Nardi NB, Sant\u2019Anna JR, et al. Direct intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy: INTRACELL, a prospective randomized controlled trial. Rev Bras Cir Cardiovasc. 2014;29:437\u201347.","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"441_CR9","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1093\/eurheartj\/ehv477","volume":"36","author":"H Martino","year":"2015","unstructured":"Martino H, Brofman P, Greco O, Bueno R, Bodanese L, Clausell N, et al. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study). Eur Heart J. 2015;36:2898\u2013904.","journal-title":"Eur Heart J"},{"key":"441_CR10","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/CIRCRESAHA.115.304554","volume":"115","author":"TD Henry","year":"2014","unstructured":"Henry TD, Traverse JH, Hammon BL, East CA, Bruckner B, Remmers AE, et al. Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy. Circ Res. 2014;115:730\u20137.","journal-title":"Circ Res"},{"key":"441_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijcard.2008.06.002","volume":"138","author":"EA Bocchi","year":"2010","unstructured":"Bocchi EA, Bacal F, Guimaraes G, Mendroni A, Mocelin A, Filho AE, et al. Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non-ischemic refractory heart failure. Int J Cardiol. 2010;138:94\u20137.","journal-title":"Int J Cardiol"},{"key":"441_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1161\/CIRCHEARTFAILURE.109.855023","volume":"2","author":"U Fischer-Rasokat","year":"2009","unstructured":"Fischer-Rasokat U, Assmus B, Seeger FH, Honold J, Leistner D, Fichtlscherer S, et al. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail. 2009;2:417\u201323.","journal-title":"Circ Heart Fail"},{"key":"441_CR13","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.jacc.2007.07.041","volume":"50","author":"MJ Lipinski","year":"2007","unstructured":"Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol. 2007;50:1761\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"441_CR14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006\u201312.","journal-title":"J Clin Epidemiol"},{"key":"441_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"441_CR16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1253\/circj.71.1199","volume":"71","author":"T Tatsumi","year":"2007","unstructured":"Tatsumi T, Ashihara E, Yasui T, Matsunaga S, Kido A, Sasada Y, et al. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ J. 2007;71:1199\u2013207.","journal-title":"Circ J"},{"key":"441_CR17","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0735-1097(97)00235-0","volume":"30","author":"BA Bart","year":"1997","unstructured":"Bart BA, Shaw LK, McCants Jr CB, Fortin DF, Lee KL, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 1997;30:1002\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"441_CR18","first-page":"15","volume":"17","author":"M Merlo","year":"2016","unstructured":"Merlo M, Gigli M, Poli S, Stolfo D, Brun F, Lardieri G, et al. Dilated cardiomyopathy: a dynamic disease\u2014clinical course, reverse remodeling and prognostic stratification. G Ital Cardiol (Rome). 2016;17:15\u201323.","journal-title":"G Ital Cardiol (Rome)"},{"key":"441_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1535370213477982","volume":"238","author":"YL Tang","year":"2013","unstructured":"Tang YL, Wang YJ, Chen LJ, Pan YH, Zhang L, Weintraub NL. Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications. Exp Biol Med (Maywood). 2013;238:294\u2013300.","journal-title":"Exp Biol Med (Maywood)"},{"key":"441_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-4939-3584-0_7","volume":"1416","author":"M Gnecchi","year":"2016","unstructured":"Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms of mesenchymal stem cells in tissue repair. Methods Mol Biol. 2016;1416:123\u201346.","journal-title":"Methods Mol Biol"},{"key":"441_CR21","doi-asserted-by":"publisher","first-page":"746873","DOI":"10.1155\/2015\/746873","volume":"2015","author":"T Fatkhudinov","year":"2015","unstructured":"Fatkhudinov T, Bolshakova G, Arutyunyan I, Elchaninov A, Makarov A, Kananykhina E, et al. Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle. Stem Cells Int. 2015;2015:746873.","journal-title":"Stem Cells Int"},{"key":"441_CR22","doi-asserted-by":"crossref","unstructured":"Yamada S, Arrell DK, Martinez-Fernandez A, Behfar A, Kane GC, Perez-Terzic CM, et al. Regenerative therapy prevents heart failure progression in dyssynchronous nonischemic narrow QRS cardiomyopathy. J Am Heart Assoc. 2015;4(5):e001614.","DOI":"10.1161\/JAHA.114.001614"},{"key":"441_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fgene.2013.00204","volume":"4","author":"T Hosoda","year":"2013","unstructured":"Hosoda T. The mircrine mechanism controlling cardiac stem cell fate. Front Genet. 2013;4:204.","journal-title":"Front Genet"},{"key":"441_CR24","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/eurheartj\/ehp220","volume":"30","author":"F Cao","year":"2009","unstructured":"Cao F, Sun D, Li C, Narsinh K, Zhao L, Li X, et al. Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4\u00a0years follow-up. Eur Heart J. 2009;30:1986\u201394.","journal-title":"Eur Heart J"},{"key":"441_CR25","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1093\/eurheartj\/ehn436","volume":"29","author":"HV Huikuri","year":"2008","unstructured":"Huikuri HV, Kervinen K, Niemela M, Ylitalo K, Saily M, Koistinen P, et al. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J. 2008;29:2723\u201332.","journal-title":"Eur Heart J"},{"key":"441_CR26","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.jacc.2015.09.010","volume":"66","author":"AA Kelkar","year":"2015","unstructured":"Kelkar AA, Butler J, Schelbert EB, Greene SJ, Quyyumi AA, Bonow RO, et al. Mechanisms contributing to the progression of ischemic and nonischemic dilated cardiomyopathy: possible modulating effects of paracrine activities of stem cells. J Am Coll Cardiol. 2015;66:2038\u201347.","journal-title":"J Am Coll Cardiol"},{"key":"441_CR27","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1161\/01.CIR.0000095029.57483.60","volume":"108","author":"D Bello","year":"2003","unstructured":"Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108:1945\u201353.","journal-title":"Circulation"},{"key":"441_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.medici.2015.07.005","volume":"51","author":"M Staniute","year":"2015","unstructured":"Staniute M, Vaskelyte J, Rumbinaite E, Kaminskaite B, Samsanaviciene S, Plungiene S, et al. Impact of left ventricular function on health-related quality of life in coronary artery disease patients. Medicina (Kaunas). 2015;51:233\u20139.","journal-title":"Medicina (Kaunas)"},{"key":"441_CR29","first-page":"236","volume":"36","author":"SP Zhou","year":"2008","unstructured":"Zhou SP, Yang CM, Shi WB, Wang XK, Zeng CY. Study on six-minute walk test and cardiac output response against exercise in patients with chronic heart failure. Zhonghua Xin Xue Guan Bing Za Zhi. 2008;36:236\u20139.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"441_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.arr.2010.05.001","volume":"9","author":"Y Bai","year":"2010","unstructured":"Bai Y, Sun T, Ye P. Age, gender and diabetic status are associated with effects of bone marrow cell therapy on recovery of left ventricular function after acute myocardial infarction: a systematic review and meta-analysis. Ageing Res Rev. 2010;9:418\u201323.","journal-title":"Ageing Res Rev"},{"key":"441_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12265-009-9149-y","volume":"3","author":"JL Herrmann","year":"2010","unstructured":"Herrmann JL, Abarbanell AM, Weil BR, Manukyan MC, Poynter JA, Wang Y, et al. Gender dimorphisms in progenitor and stem cell function in cardiovascular disease. J Cardiovasc Transl Res. 2010;3:103\u201313.","journal-title":"J Cardiovasc Transl Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0441-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-016-0441-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0441-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T06:27:02Z","timestamp":1637044022000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-016-0441-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1186\/s13287-016-0441-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"23 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"186"}}